D.A. Davidson & Co’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-6,266
Closed -$452K 1359
2022
Q1
$452K Sell
6,266
-373
-6% -$26.9K ﹤0.01% 907
2021
Q4
$610K Sell
6,639
-3,204
-33% -$383K 0.01% 813
2021
Q3
$1.25M Buy
9,843
+1,206
+14% +$176K 0.01% 565
2021
Q2
$1.44M Buy
8,637
+582
+7% +$94.3K 0.02% 526
2021
Q1
$1.46M Buy
8,055
+1,787
+29% +$414K 0.02% 475
2020
Q4
$1.25M Buy
6,268
+2,858
+84% +$581K 0.02% 456
2020
Q3
$748K Buy
3,410
+939
+38% +$199K 0.01% 521
2020
Q2
$472K Sell
2,471
-2,109
-46% -$370K 0.01% 616
2020
Q1
$710K Buy
4,580
+780
+21% +$90.7K 0.01% 521
2019
Q4
$318K Buy
3,800
+333
+10% +$25.3K 0.01% 798
2019
Q3
$235K Buy
3,467
+360
+12% +$23.7K ﹤0.01% 869
2019
Q2
$206K Sell
3,107
-2,535
-45% -$148K ﹤0.01% 902
2019
Q1
$314K Buy
+5,642
New +$344K 0.01% 861
2018
Q4
Sell
-2,434
Closed -$210K 1162
2018
Q3
$210K Buy
+2,434
New +$173K ﹤0.01% 1058
2017
Q3
Sell
-1,139
Closed -$39K 1891
2017
Q2
$39K Buy
+1,139
New +$33.2K ﹤0.01% 1613

Other funds holding TDOC

D.A. Davidson & Co's TDOC Position: Q2 2022 in Review

D.A. Davidson & Co sold out of Teladoc Health (TDOC) in Q2 2022, closing a stake of 6,266 shares — an estimated $452K sold.

D.A. Davidson & Co first reported a position in TDOC in Q2 2017 and held it in 15 quarters. The position peaked at $1.46M in Q1 2021. 551 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.

  • D.A. Davidson & Co reported no remaining Teladoc Health position as of Q2 2022 after selling out during the quarter.
  • D.A. Davidson & Co sold 6,266 Teladoc Health shares in Q2 2022, an estimated $452K.
  • D.A. Davidson & Co first reported a position in Teladoc Health in Q2 2017 and held it in 15 quarters.
  • D.A. Davidson & Co's Teladoc Health position peaked at $1.46M in Q1 2021.
  • 551 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.

Based on D.A. Davidson & Co's 13F filing for Q2 2022, filed 28 Jul 2022.